Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years
Clinical trial NCT04026984 · UNKNOWN
Trial details
- NCT number
- NCT04026984
- Sponsor
- RedHill Biopharma Limited
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-06-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.